IGC - India Globalization Capital Receives Patent To Treat Alzheimer's With Cannabis Drug
- India Globalization Capital was awarded a patent to treat Alzheimer’s Disease using a low dose THC drug.
- They are currently completing their Phase 1 human clinical trial with the THC drug.
- The company has introduced several wellness and lifestyle CBD brands during PY-2021.
- The company’s 2021 financials show huge losses due to COVID-19 disruptions, but they raised $14M from ATM offerings.
- I rate the company as a neutral buy but highly encourage that you watch the stock and await news from the company.
For further details see:
India Globalization Capital Receives Patent To Treat Alzheimer's With Cannabis Drug